日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.

AXL 的异常激活可能驱动 CLL 患者鳞状细胞癌的进展:一项具有临床意义的机制研究

Sinha Sutapa, Guo Ray, Del Busso Miles D, Han Weiguo, Boysen Justin, Wellik Linda E, Ghosh Asish K, Kay Neil E

B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells

在慢性淋巴细胞白血病B细胞中,B细胞受体信号通过直接增强子调控驱动APOBEC3表达。

Wang, Zhiquan; Yan, Huihuang; Boysen, Justin C; Secreto, Charla R; Tschumper, Renee C; Ali, Dania; Guo, Qianqian; Zhong, Jian; Zhou, Jiaqi; Gan, Haiyun; Yu, Chuanhe; Jelinek, Diane F; Slager, Susan L; Parikh, Sameer A; Braggio, Esteban; Kay, Neil E

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.

水杨酸盐通过诱导 S 期阻滞和损害 DNA 损伤修复来增强 CRM1 抑制剂的抗肿瘤活性

Abeykoon Jithma P, Wu Xiaosheng, Nowakowski Kevin E, Dasari Surendra, Paludo Jonas, Weroha S John, Hu Chunling, Hou Xiaonan, Sarkaria Jann N, Mladek Ann C, Phillips Jessica L, Feldman Andrew L, Ravindran Aishwarya, King Rebecca L, Boysen Justin, Stenson Mary J, Carr Ryan M, Manske Michelle K, Molina Julian R, Kapoor Prashant, Parikh Sameer A, Kumar Shaji, Robinson Steven I, Yu Jia, Boughey Judy C, Wang Liewei, Goetz Matthew P, Couch Fergus J, Patnaik Mrinal M, Witzig Thomas E

Upregulation of AXL and β-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance

在与骨髓基质细胞共培养的慢性淋巴细胞白血病细胞中,AXL 和 β-catenin 的上调与耐药性的增强相关。

Sinha, Sutapa; Secreto, Charla R; Boysen, Justin C; Lesnick, Connie; Wang, Zhiquan; Ding, Wei; Call, Timothy G; Kenderian, Saad J; Parikh, Sameer A; Warner, Steven L; Bearss, David J; Ghosh, Asish K; Kay, Neil E

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre

在一家学术医疗中心的常规临床实践中,接受伊布替尼治疗的慢性淋巴细胞白血病患者出现自身免疫性血细胞减少症

Hampel, Paul J; Larson, Melissa C; Kabat, Brian; Call, Timothy G; Ding, Wei; Kenderian, Saad S; Bowen, Deborah; Boysen, Justin; Schwager, Susan M; Leis, Jose F; Chanan-Khan, Asher A; Muchtar, Eli; Hanson, Curtis A; Slager, Susan L; Kay, Neil E; Chaffee, Kari G; Shanafelt, Tait D; Parikh, Sameer A

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study

Akt抑制剂MK-2206联合苯达莫司汀和利妥昔单抗治疗复发或难治性慢性淋巴细胞白血病:N1087联盟研究结果

Larsen, Jeremy T; Shanafelt, Tait D; Leis, Jose F; LaPlant, Betsy; Call, Tim; Pettinger, Adam; Hanson, Curtis; Erlichman, Charles; Habermann, Thomas Matthew; Reeder, Craig; Nikcevich, Daniel; Bowen, Deborah; Conte, Michael; Boysen, Justin; Secreto, Charla; Lesnick, Connie; Tschumper, Renee; Jelinek, Diane; Kay, Neil E; Ding, Wei

Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia

简报:临床确诊的单克隆B细胞淋巴细胞增多症患者与Rai 0型慢性淋巴细胞白血病患者的自然病程比较

Shanafelt, Tait D; Kay, Neil E; Rabe, Kari G; Call, Timothy G; Zent, Clive S; Maddocks, Kami; Jenkins, Greg; Jelinek, Diane F; Morice, William G; Boysen, Justin; Schwager, Susan; Bowen, Deborah; Slager, Susan L; Hanson, Curtis A

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression

间充质干细胞与慢性淋巴细胞白血病B细胞之间的双向激活:对慢性淋巴细胞白血病疾病进展的意义

Ding, Wei; Nowakowski, Grzegorz S; Knox, Traci R; Boysen, Justin C; Maas, Mary L; Schwager, Susan M; Wu, Wenting; Wellik, Linda E; Dietz, Allan B; Ghosh, Asish K; Secreto, Charla R; Medina, Kay L; Shanafelt, Tait D; Zent, Clive S; Call, Timothy G; Kay, Neil E